Metabolic responses in endothelial cells following exposure to ketone bodies by E. Meroni et al.
nutrients
Article
Metabolic Responses in Endothelial Cells Following
Exposure to Ketone Bodies
Erika Meroni 1 ID , Nadia Papini 2 ID , Franca Criscuoli 1, Maria C. Casiraghi 1 ID , Luca Massaccesi 3,
Nicoletta Basilico 4 and Daniela Erba 1,* ID
1 Human Nutrition Unit, Department of Food, Environmental and Nutritional Sciences DeFENS,
Università degli Studi di Milano, Via Celoria, 2, 20133 Milan, Italy; erika.meroni@unimi.it (E.M.);
franca.criscuoli@unimi.it (F.C.); maria.casiraghi@unimi.it (M.C.C.)
2 Department of Medical Biotechnology and Translational Medicine, L.I.T.A., Università degli Studi di Milano,
Via F.lli Cervi, 93, 20090 Segrate, Milan, Italy; nadia.papini@unimi.it
3 Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Via Saldini, 50,
20133 Milan, Italy; luca.massaccesi@unimi.it
4 Department of Biomedical Sciences, Surgical and Dental Sciences, Università degli Studi di Milano,
Via C. Pascal, 36, 20133 Milan, Italy; nicoletta.basilico@unimi.it
* Correspondence: daniela.erba@unimi.it; Tel.: +39-2-5031-6644
Received: 6 December 2017; Accepted: 14 February 2018; Published: 22 February 2018
Abstract: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet based on the induction of
the synthesis of ketone bodies (KB). Despite its widespread use, the systemic impact of KD is not
completely understood. The purpose of this study was to evaluate the effects of physiological levels
of KB on HMEC-1 endothelial cells. To this aim, DNA oxidative damage and the activation of
Nrf2, a known transcriptional factor involved in cell responses to oxidative stress, were assessed.
The exposure of cells to KB exerted a moderate genotoxic effect, measured by a significant increase in
DNA oxidative damage. However, cells pre-treated with KB for 48 h and subjected to a secondary
oxidative insult (H2O2), significantly decreased DNA damage compared to control oxidized cells.
This protection occurred by the activation of Nrf2 pathway. In KB-treated cells, we found increased
levels of Nrf2 in nuclear extracts and higher gene expression of HO-1, a target gene of Nrf2, compared
to control cells. These results suggest that KB, by inducing moderate oxidative stress, activate the
transcription factor Nrf2, which induces the transcription of target genes involved in the cellular
antioxidant defense system.
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1. Introduction
One of the dietary approaches that has attracted particular success in recent years is the “ketogenic
diet” (KD). This is a dietary program that was designed in the 1920s as a therapy for drug-resistant
epilepsy [1,2], which then gained popularity in the 1970s as a weight-loss diet (Atkins) [3,4]. Currently,
there are many diets that are based on this model. Recently, KD has also been proposed for a number
of neurological disorders like Parkinson’s and Alzheimer’s diseases [5–7].
The KD is a high-fat, low carbohydrates diet planned to achieve a metabolic state called ketosis,
characterized by increased levels of circulating ketone bodies (KB), i.e., the compounds acetoacetate
(AA), β-hydroxybutyrate (βHB) and acetone. Under normal conditions and with a balanced diet, KB
are produced in small quantities, but, under a KD, their synthesis is induced as a result of a very low
carbohydrate intake (VLCKD) and high fat intake. The low glucose supply stimulates the catabolism
of fats to obtain energy, leading to the accumulation of acetyl-CoA and synthesis of KB by the liver,
which are sent to the peripheral tissues where they are oxidized to produce energy [8–10].
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Despite its multiple applications, the impact of KD on the human body is not completely
understood. Several studies have been performed to clarify the mechanisms by which KD achieves
neuroprotection [11–13], whereas less is known about the systemic effects of KB circulating in the
bloodstream. The adverse effects of KD on the cardiovascular system have not been well documented
and are still controversial. For instance, some studies observed, in epileptic patients treated with KD,
an increase of serum levels of cholesterol, triglycerides and LDL, known risk factors for CVD [14,15],
and changes in vascular structure and function are also reported [16]. On the other hand, the
consumption of KD, in non-epileptic subjects, has been mostly associated with an improvement
in some cardiovascular risk factors, even though the effect of long term use of KD and its lipid
composition should be better assessed [17].
Endothelial dysfunction is another key risk factor for CVD, often resulting from cellular oxidative
unbalance [18,19]. Consequently, it appears critical to investigate the KB effects on endothelial
model, taking into consideration that KB exposure has been shown to alter red-ox cellular state.
In hippocampal cells of mice, KB and in particular AA, seem to exert a protective effect, by defending
cells against oxidative stress induced by glutamate [11]. Jarrett and colleagues showed that KD
stimulates the biosynthesis of reduced glutathione (GSH) in rat hippocampal mitochondria, specifically
by increasing mitochondrial GSH levels and improving redox status, thereby resulting in lower
production of ROS [12]. A recent review suggests a further potential mechanism of KD, by means of
the production of redox signalling molecules. Under these conditions, KD induced adaptive cellular
responses in the hippocampus of rats, such as activation of the transcription factor Nrf2 (nuclear factor
erythroid 2-related factor 2) [13].
Nrf2 is normally sequestered in the cytoplasm by binding to the protein Keap1 (kelch ECH
associating protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, which constantly
ubiquitinates Nrf2, targeting it for the proteasome where is degraded. When stress occurs, Keap1 is
inactivated and Nrf2 is stabilized; however, Nrf2 does not dissociate from inactivated Keap1, so de
novo synthesized Nrf2 translocates into the nucleus. There, it forms a heterodimer with small Maf
(sMaf) proteins and activates the transcription of target genes by binding to antioxidant response
elements (ARE) [20–26].
Among the enzymes up-regulated by Nrf2, one of the most important is HO-1, which catalyzes
the conversion of heme into biliverdin, carbon monoxide and free iron, and has both anti-inflammatory
and antioxidant properties [27–30]. It has been seen, in an animal model, that HO-1 increases in the
liver of KD-fed rats compared to control rats after three weeks [31]. So, the activation of Nrf2 may be
one of the main mechanisms explaining the positive effects exerted by KB [13,31].
In the present study we focused our attention to assess, by in vitro model, the vascular risk
represented by KD-induced oxidative stress. We hypothesized that treatment with the KB would
induce Nrf2 nuclear localization and antioxidant protein activation, protecting cells against a following
oxidative challenge. To this aim we investigated, by an in vitro model of endothelium, (1) whether the
exposure to KB might directly exert an oxidative damage to DNA; (2) the ability of KB to modulate
DNA susceptibility toward a secondary oxidative insult and (3) the endothelial cell adaptive metabolic
response to KB exposure, by activation of the Nrf2 pathway.
2. Materials and Methods
2.1. Materials
A long-term cell line of human microvascular endothelial cells (HMEC-1) immortalized by
simian-virus-40 large T antigen [32] was provided by the Centers for Disease Control and Prevention,
Atlanta, GA, USA. Due to its immortalization, it is necessary to consider that this cell line might have
acquired some tumor features. However, HMEC-1 has widely been used as a model for studying
endothelial dysfunction [33–35]. It has been reported that this cell line retains the morphologic,
phenotypic and functional characteristics of normal human microvascular endothelial cells [32].
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Moreover, comparing different endothelial cell lines, HMEC-1 is considered the most suitable
model to investigate microvascular endothelium [36]. All cell culture reagents, chemicals and both
β-hydroxybutyric acid (298360) and acetoacetic acid lithium (A8509) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
2.2. Cell Culture
HMEC-1 cells were cultivated in MCDB131 medium supplemented with 10% fetal bovine serum,
10 ng/mL epidermal growth factor, 1 µg/mL hydrocortisone, 2 mM glutamine, 100 U/mL penicillin,
100 µg/mL streptomycin and 20 mM HEPES buffer. Cells were passaged every 3–4 days.
For the analysis, cells were seeded at a density of 5 × 104 cells/cm2 in 60 mm Petri dishes and
allowed to reach confluence in 24 h; then, cells were supplemented with KB dispersed in complete
medium, and incubated at 37 ◦C in an atmosphere containing 5% of CO2 (2–48 h time points), according
to the experimental design.
2.3. Treatment with AA and βHB
Stock solutions for AA and βHB were prepared in sterilized water. HMEC-1 cells were
supplemented with different concentrations of KB: from 2 to 20 mM for βHB and from 0.5 to 5 mM
for AA. Previous studies have reported that βHB and AA occur in vivo after the induction of ketosis
in a ratio of 4:1, respectively [8]. To simulate the physiological condition both βHB and AA were
incorporated simultaneously in cell treatments.
2.4. Cell Viability
Cell viability was determined by the MTT reduction assay [37]. HMEC-1 cells were incubated for
24, 48 and 72 h in 24-well plates after the supplementation with KB. Complete medium containing
10% MTT was added to treated and control cells in each well. The cells were incubated at 37 ◦C for
2 h, the supernatants were removed, and 1 mL of a solution of isopropanol/1 N HCl (24/1 v/v) was
added. Absorbance was recorded at a wavelength of 590 nm and a reference wavelength of 630 nm
using a microplate reader (Multiskan Go, Thermo Fisher Scientific, Waltham, MA, USA). Viability was
expressed as the percentage of treated vs. control set at 100%.
2.5. Comet Assay
Based on the results of the viability test, cells were exposed to KB (βHB 4 mM, AA 1 mM) for 2,
24 and 48 h at 37 ◦C with 95% humidity and 5% CO2. Every treatment was performed in triplicate;
negative (cells without KB) and positive (cells treated with H2O2: 50 µM for 5 min) controls were
included in each batch. After incubation, an aliquot of cells was used to verify cell viability via the
trypan blue exclusion test [38], to be sure that cells were suitable for the comet assay. Another aliquot
of cells was centrifuged (11,000× g, for 15 s; SL16R Thermo Fisher Scientific), re-suspended in 1.5%
low melting point agarose, and spread on a microscope slide previously covered with 1% normal
melting point agarose. Embedded cells were lysed, DNA was allowed to unwind in electrophoresis
buffer (pH 10) and then electrophoresis was performed at 25 V and 300 mA for 20 min. The slides were
then immersed in neutralization buffer for 15 min, stained with ethidium bromide and analyzed using
a fluorescence microscope (BX60 Olympus, Tokyo, Japan) equipped with Image-Pro Plus software
(Immagini & Computer, Bareggio; Milano, Italy). Fifty images were analyzed for each slide and the tail
moment was registered. DNA damage was expressed as the percentage of DNA in the tail [39,40].
2.6. RNA Extraction and Gene Expression
Total RNA was isolated with the RNeasy Mini Kit (Qiagen, Hilden, Germany), according to the
manufacturer’s protocol. Then, 0.8 µg of RNA was reverse-transcribed employing the iScript cDNA
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). Real-Time PCR was performed using an
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iCycler thermal cycler (Bio-Rad Laboratories) with cDNA corresponding to 10 ng of total RNA as the
template. The PCR mixture included 0.2 µM primers and 1X SYBR Green PCR Master Mix (Bio-Rad
Laboratories) in a final volume of 20 µL. The primer sequences are provided in Table 1.
Table 1. List of primer used for real-time reverse transcription-polymerase chain reaction (RT-PCR).
Genes Primer Sequences
Nrf2 F: 5′-AGCACATCCAGTCAGAAACC-3′ R: 5′-TGAAACGTAGCCGAAGAAAC-3′
HO-1 F: 5′-CAACATCCAGCTCTTTGAGG-3′ R: 5′-AGAAAGCTGAGTGTAAGGAC-3′
GAPDH F: 5’-AGGGCTGCTTTTAACTCTGG-3′ R: 5′-CATGGGTGGAATCATATTGG-3′
Amplification and real-time data acquisition were performed using the followed cycle conditions:
initial denaturation at 95 ◦C for 3 min, followed by 45 cycles of 10 s at 95 ◦C and 30 s at 58 ◦C. The fold
change in expression of the different genes in treated HMEC-1 cells compared with control cells
was normalized to the expression of GAPDH and was calculated by the equation 2-∆∆Ct using iQ5
software version 2.0 (Bio-Rad Laboratories, Hercules, CA, USA). All reactions were performed in
triplicate, and the accuracy was monitored by analysis of the PCR product melting curve.
2.6.1. Nuclear Compartment Isolation
After treatment, cells were harvested by scraping into PBS and were then centrifuged at 400× g for
10 min at 4 ◦C. Cell pellets were lysed for 10 min at 4 ◦C with a buffer containing 10 mM HEPES pH 8.0,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT), 0.05% Nonidet P-40 (NP-40), 1 mM Na3VO4
and protease inhibitors. Lysates were centrifuged at 2500× g at 4 ◦C for 10 min, the supernatants
(including cytoplasm) were collected in new tubes and the nuclear pellets were resuspended in a
lysis buffer containing 20 mM HEPES pH 8.0, 1.5 mM MgCl2, 420 mM NaCl, 1.0 mM DTT, 0.2 mM
EDTA, 1 mM Na3VO4 and protease inhibitors for 30 min at 4 ◦C. The nuclear extracts were clarified by
centrifugation (10,000× g at 4 ◦C for 5 min) and collected in new tubes.
The concentration of protein in the samples was measured by Bradford’s method [41].
2.6.2. Western Blot Analysis
Proteins were denatured by boiling for 5 min in sodium dodecylsulfate (SDS) sample
buffer, loaded into 10% SDS-PAGE gels and subsequently transferred onto PVDF membranes by
electroblotting. Then, the PVDF membranes were incubated in Tris-buffered Saline with 0.1% (v/v)
Tween 20 (TBS-T) containing 5% (w/v) non-fat dried milk or 5% (w/v) bovine serum albumin
(BSA; Sigma) for 1 h. Blots were incubated with primary antibodies in the appropriate blocking
solution at 4 ◦C overnight. The following primary antibodies were used: Nrf2 (C-20, Santa Cruz
Biotechnology, Inc., Dallas, TX, USA) dilution 1:400 in TBS-T+5% (w/v) non-fat dried milk; GAPDH
(FL-335, Santa Cruz Biotechnology, Inc.) dilution 1:500 in TBS-T+5% (w/v) non-fat dried milk; lamin
A/C (N-18, Santa Cruz Biotechnology, Inc.) dilution 1:500 in TBS-T+5% BSA. Membranes were washed
three times for 10 min and then incubated with the appropriate secondary antibody conjugated
with horseradish peroxidase for 1 h. For the immunological detection of proteins, the enhanced
chemiluminescence system (Pierce Biotechnology, Waltham, MA, USA) was used. The acquisition of
PVDF membrane images and the densitometric analysis of blots was performed using an Alliance MINI
HD9 (UVItec) apparatus (Cleaver Scientific, Warwickshire, United Kingdom) and related software.
2.7. Statistical Analysis
Experimental results re expressed as mean ± SD of three (four for western blot) independent
measurements. The data for various parameters were analyzed by one-way analysis of variance
(ANOVA) with SPSS Statistics 22 (IBM). Significant differences (p < 0.001 for comet assay analysis,
p < 0.05 for viability, western blot and PCR analysis) were detected by the Tukey test.
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3. Results
3.1. Cell Viability
To test the toxicity of KB on endothelial cells, HMEC-1 cells were treated with various
concentrations of βHB and AA for different times (24, 48 and 72 h). Concentrations up to 4 mM
βHB and 1 mM AA showed no significant effects on cell viability up to 48 h (Figure 1). Higher
concentrations were harmful at 48 h, and lower concentrations were damaging at 72 h. Considering
this outcome, and assuming that 48 h is an appropriate time to detect a metabolic cellular response to
an external stimulus, all further investigations were performed on HMEC-1 cells exposed to 4 mM
βHB and 1 mM AA.
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Figure 2. Analysis of DNA damage in HMEC-1 cells treated with KB (4 mM βHB, 1 mM AA) for 2, 24
or 48 h (A) and subsequently oxidized with 50 µ H2O2 for 5 min (B); results are expressed as the %
of DNA in the tail (mean ± SD). Data not sharing a common letter are significantly different, p < 0.001.
Nutrients 2018, 10, 250 6 of 13
Effects of KB Exposure on Secondary Oxidative Insult
DNA damage was evaluated in cells supplemented or not with KB (again for 2, 24 or 48 h),
and subsequently subjected to an oxidative insult, represented by H2O2 50 µmol/L for 5 min.
The results are presented in Figure 2B. Firstly, there was a net increase in oxidative DNA damage in
control cells exposed to H2O2 (C = 2.03 ± 0.21 vs. C + OX = 60.92 ± 2.73, % DNA in the tail, p < 0.001);
cells previously treated with KB and exposed to H2O2 showed DNA damage as well. However, as the
duration of exposure to KB increased, the DNA damage decreased. In fact, there was a significant
decrease, equal to −36% (p < 0.001), in H2O2-induced oxidative DNA damage in the cells treated
with KB for 48 h (KB48 + OX = 39 ± 2.42% DNA in the tail) compared to the oxidized control cells
(C + OX = 60.92 ± 2.73% DNA in the tail). This result suggests a protective effect of KB, which appears
able to activate, within 48 h, a positive response by the cells, which confers them protection against a
secondary oxidative insult (in this case due to H2O2).
3.3. Gene and Protein Expression of Nrf2
Nrf2 is a primary transcription factor involved in the cellular response to oxidative stress. When
stress occurs, the Nrf2-Keap1 complex is disrupted, resulting in the stabilization of Nrf2, which
can translocate to the nucleus where it activates the transcription of target genes by binding to the
ARE [20–24]. HMEC-1 cells were exposed to KB for 2, 6, 14 and 24 h. Regarding the gene expression
of Nrf2, a significant increase was observed at 2 h in KB-treated cells compared to control cells
(C = 0.89 ± 0.02, KB2h = 1.01 ± 0.01, variation about 13% vs. control, p < 0.05). On the contrary, at later
time points, there was a decrease in Nrf2 mRNA levels (KB6h = 0.82 ± 0.08, KB14h = 0.66 ± 0.03,
KB24h 0.58 ± 0.01, p < 0.05) (Figure 3). The western blot analysis showed an increase in the total
amount of Nrf2 at 2 h (by about 30%) in cells treated with KB compared to the control cells. Moreover,
considering only the nuclear extracts, the amount of Nrf2 was greater in KB-treated cells than in the
control. Particularly, as reported in Figure 4C, looking at the level of Nrf2 in the nucleus compared
to the total amount of Nrf2 in the whole cell (both cytoplasmic and nuclear extracts), there was a
significant difference at 2 h in cells treated with KB compared to control cells (KB2h = 50.30 ± 2.2;
Control = 34.95 ± 2.9, % vs. total, p < 0.05).
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Figure 4. Western blot analysis. Nrf2 protein expression in control cells or cells treated with KB for
2, 6, 14 or 24 h in the nuclear (A) and cytoplasmic (B) fractions. Lamin A/C was used as a nuclear
marker. GAPDH was used as a cytoplasmic marker. The western blot image is representative of four
independent experiments (A,B). Densitometric analysis of Nrf2 protein expression was performed
using lamin A/C as the loading control and Nrf2 nuclear translocation are expressed as the % of Nrf2
in the nuclear fraction compared to the total amount of Nrf2 in whole cells. Data are the mean ± SD of
four independent experiments. Data not sharing a common letter are significantly different, p < 0.05 (C).
3.4. Activation of the Nrf2 Pathway: HO-1 Gene Expression
Activation of the Nrf2 pathway was investigated by assessing the gene expression of HO-1.
The data show that HO-1 mRNA levels were significantly higher in cells treated with KB compared to
control cells, at all time points measured (Figure 5). The greatest increases in mRNA levels occurred
after 2 h and 6 h of treatment with KB (C = 0.40 ± 0.05, KB2h = 1.00, KB6h = 0.91± 0.01, p < 0.05),
while at later time points there was a decrease, but the values were still higher than in control cells
(KB14h = 0.53 ± 0.09, KB24h = 0.65 ± 0.03, p < 0.05).
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4. Discussion
The present study was designed to investigate the effects of exposure to KB in HMEC-1 endothelial
cells by measuring markers of oxidative stress and metabolic responses. Primarily, our results
demonstrate that βHB and AA, at concentrations equal to 4 mM and 1 mM, respectively, induced
moderate oxidative stress, detectable by a significant increase in oxidative damage to DNA after 2 h.
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In literature conflicting data are reported concerning the production of ROS by KB and
KD. For instance, in cancer models, some studies [43,44] found ROS reduction owing to KB
metabolism, while other studies reported increased oxidative stress [45], or no change [46]. In primary
cells, according to Veech, the metabolism of KB should reduce the amount of Q semiquinone,
thereby decreasing ROS production in primary cells [47]. However, other investigations showed
conflicting results. Shi et al. investigated the pro-oxidant activities of βHB in primary calf liver cells.
After treatment with various concentrations of βHB for 24 h, they demonstrated that βHB increased
the oxidizing species and decreased antioxidant defenses, causing stress at least within 24 h [48].
Another study, using mitochondria from the hippocampus of rats fed a KD, seem to confirm this thesis,
as an increase in H2O2 was shown at the beginning of the diet, while a decrease was observed after
more extended periods of the diet. Moreover, the levels of 4-HNE were also higher in the KD group
compared to controls. Overall, these data suggest the induction of mild oxidative stress immediately
after the beginning of a KD [31]. Regarding endothelial cells, it has been demonstrated that KB can
generate oxygen radical and overall contribute to increased oxidative stress. In particular, it was shown
that elevated levels of KB can result in lipid peroxidation, which is apparently increased by oxygen
radicals generated by AA [49]. Accordingly, the study of Kanikarla-Marie et al., confirmed these
results demonstrating, in HUVEC cells, that ketones cause increased oxidative stress by up-regulating
NADPH oxidase 4 [50]. Thus, recent data are in agreement with the results highlighted by our analysis,
which underlines the induction of moderate oxidative stress at the cellular level due to the presence of
KB. However, this stress was not related to the duration of exposure. We did not find any significant
differences in DNA damage among the three time points of exposure (2, 24 and 48 h). It might be
hypothesized that, during 48 h of treatment, the oxidative stress generated at 2 h induced some cellular
metabolic responses. The activation of antioxidant enzymes could be one of the protective mechanisms
promoted by the cell as a consequence of KB-induced stress.
In order to investigate our hypothesis regarding the cellular response to KB, we decided to expose
HMEC-1 cells to KB and later to a secondary oxidative insult, in our study represented by H2O2.
Among the stimuli used to produce quantifiable oxidative damage to DNA and modulated by the
presence of antioxidants, hydrogen peroxide has proved to be the most effective and reproducible [51,52];
therefore, it was used in this study. Surprisingly, oxidized cells previously treated with KB for 48 h
showed significantly less DNA damage compared to control oxidized cells. This interesting result
suggests that KB, by causing moderate oxidative stress detectable based on oxidative DNA damage,
at a subsequent time point, are able to activate a cellular response that results in protection against a
secondary insult. The beneficial effects of KB have been investigated before to understand their role in
some pathologies, above all in epilepsy, but also in other neurological diseases and cancer. In particular,
Noh et al. discovered that AA protects neuronal cells from oxidative glutamate toxicity. Their study
was showed a significant decrease in glutamate-induced ROS production in cells treated with AA
compared with cells treated with glutamate alone [11]. To test the possible protective role of βHB
against oxidative stress, Shimatzu et al., implanted mice with subcutaneous pump delivering βHB or
PBS for 24 h. Then mice received an intravenous injection of paraquat, which produces superoxide
anions. The authors found that paraquat treatment of control mice receiving PBS led to an increase in
carbonylated proteins, while this increase was significantly prevented in βHB-treated mice. Similarly,
the increase of 4-HNE was suppressed in mice treated with βHB [53]. Another interesting paper
published by Jarrett and colleagues reported that KD increases mitochondria GSH levels, resulting in
decreased mitochondrial ROS production and the protection of mitochondrial DNA in rats fed a KD
for three weeks [12]. Consistently with these published studies, our data suggest the capacity of KB to
promote cellular responses that result in the prevention of oxidative damage induced by a secondary
stressor, possibly by activating the antioxidant defense system.
One possible mechanism by which this protection might occur is through activation of the Nrf2
pathway [13,54]. As a transcription factor, Nrf2 regulates many adaptive cytoprotective responses
to counteract the deleterious effect of ROS. Several studies have indicated that increased nuclear
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translocation of this protein protects against oxidative stress injury [55,56]. Therefore, we first evaluated
Nrf2 gene expression, then its translocation into the nucleus. We decided to expose HMEC-1 cells to
KB for 2, 6, 14 or 24 h, because we hypothesized that the activation of a cellular response would happen
quickly, as we saw protection at 48 h. According to the gene expression data, it seems that there was
very rapid stabilization of Nrf2, which implies the fast de novo synthesis of Nrf2, as we saw higher
mRNA Nrf2 levels at 2 h. Even though we did not observe higher levels of Nrf2 mRNA expression
from 6 to 24 h, this does not mean that Nrf2 was not active. Actually, it has been previously reported
that some agents can increase the nuclear translocation of Nrf2, but not alter its gene expression
level [55,57,58]. Moreover, these findings on the gene expression of Nrf2 are consistent with the
results obtained from the western blot analysis, which showed an increase in the total amount of Nrf2
in KB-treated cells compared to control as well as nuclear accumulation already at 2 h. This trend
regarding Nrf2 nuclear accumulation implies that the link between Nrf2 and Keap1 has changed,
leading to stabilization of the transcription factor, which was not degraded by the proteasome, thereby
promoting its translocation into the nucleus. It could be possible that KB initially causes the production
of low levels of ROS, which may serve as a redox signaling stimulus and activate the transcription
factor Nrf2. In 2010, Milder et al. proposed for the first time that the consumption of KD activates the
Nrf2 pathway. Indeed, they observed Nrf2 accumulation in nuclear fractions from the hippocampus
and liver of rats fed a KD for up to three weeks, suggesting chronic Nrf2 activation and nuclear
translocation [13]. Most recently, another research group investigated the impact of KD on tumor
growth in an animal model, and reported that one of the protective mechanisms against cancer was
the stimulation of several factors, including Nrf2 [54]. Although the dietary intervention with KD was
different in the two studies, both of them clearly showed higher Nrf2 nuclear levels.
To further confirm the involvement of the Nrf2 pathway, we analyzed the gene expression of
HO-1, one of its target genes. Among the antioxidant proteins highly regulated by Nrf2, HO-1 was
chosen because the redox-dependent Keap1/Nrf2 system plays a central role in HO-1 induction in
response to oxidative stress [29,55]. The results show an increase in HO-1 gene expression at all time
points, notably after 2 and 6 h of KB treatment, confirming activation of the Nrf2/HO-1 pathway,
in accordance with published studies [55,59,60]. A number of studies have shown that activation of
the Nrf2/HO-1 pathway protects different kinds of cells [55–58] and, additionally, this pathway has
been considered in papers specifically related to the effects of KD [13,54]. In particular, Milder et al.
proposed a new mechanism of action of KD that involves Nrf2 activation. They suggested that the Nrf2
pathway is systemically activated by KD via redox signalling, leading to chronic cellular adaptation
and the induction of protective proteins. Indeed, in their study, both Nrf2 and HO-1 protein expression
were higher after the consumption of a KD [13]. Furthermore, a more recent study that investigated the
long-term effects of a KD in order to understand its effect on tumor growth confirmed the hypothesis
described above. In fact, the authors observed an increase in Nrf2 levels in rats treated with a KD
compared to control [54]. Both these studies are in accordance with the results obtained in the current
study and overall demonstrate rapid activation of the Nrf2 pathway after KB-induced stress.
Further studies, planned in order to evaluate the effects of AA and βHB individually
supplemented, should clarify their specific influence on DNA oxidative damage and Nrf2 activation.
Moreover, it will be interesting to assess the expression of multiple Nrf2 target genes, in addition to
HO-1, to further confirm KB activation of Nrf2 pathway.
5. Conclusions
Our results demonstrate the activation of a metabolic response in the cell due to effect of KB
exposure. KB induce moderate oxidative stress, which activates the transcription factor Nrf2. Indeed,
Nrf2 is stabilized and translocates into the nucleus. Here, Nrf2 binds to the ARE and activates the
transcription of target genes, including HO-1. Consequently, the metabolic response caused by KB
exposure makes cells more resistant to a secondary insult, in this case H2O2, leading to a reduction in
DNA oxidative damage (Figure 6).
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The novelty of our paper is that the effects of KB were investigated in endothelial cells, somewhat
distant from the neurological context. It is important to underline that KB, and more generally a KD,
could have an impact on cell metabolism in different tissue functions. The beneficial effects of a KD
applied as a therapy have been clearly demonstrated [1,2,5,7], but the use of this diet as a weight
loss method is still controversial. The mechanism hypothesized here is that KB could activate the
transcription factor Nrf2, which enhances the cellular capacity to detoxify and eliminate harmful
substances by the activation of cellular defense processes [20–22]. Actually, it is worth noting that the
up-regulation of Nrf2 does not always lead to protection; for example, it may promote carcinogenesis
in certain tissues. This could happen due to the other activities of Nrf2, such as suppression of
apoptosis, improvement of mitochondrial function and redirection of glucose metabolism t ward
NADPH generation and anabolic pathways, which overall lead to cell proliferation [23,54,61,62].
Finally, it should be considered that the activation of Nrf2 is the result of impaired oxidative cell status,
and could be harmful in the long term. A careful assessment of the risk-benefit ratio should be done
every time that a KD is applied, for therapeutic purposes or not.
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